Bachrodt Amy sold MAZE
April 1, 2026 · Form 4 insider transaction
Bachrodt Amy sold 300 shares of Maze Therapeutics, Inc. at $30.34 per share, a transaction worth $9.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
300
Price
$30.34
Total value
$9.1K
InsiderBachrodt Amy
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 2, 2026
Shares owned after12,965
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 29, 2025.; The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.05 to $30.50 per share, inclusive.